Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NVO

Novo Nordisk ADR

Nov 13 • 04:00PM ET

49.16

-1.10 -2.19 %

Healthcare • Drug Manufacturers - General • Denmark • NYSE

Peers: LLY MRK ABBV JNJ AMGN AZN PFE SNY BMY GSK

| Held by: PPH AVDE PVAL WCMI PID RVER APIE DFIC DIVZ OZEM

Scroll to Statements

Index	-	P/E	14.32	EPS (ttm)	3.43	Insider Own	0.01%	Shs Outstand	3.37B	Perf Week	5.70%
Market Cap	165.60B	Forward P/E	13.07	EPS next Y	3.76	Insider Trans	0.00%	Shs Float	3.37B	Perf Month	-13.33%
Enterprise Value	176.40B	PEG	1.75	EPS next Q	0.93	Inst Own	8.60%	Short Float	0.84%	Perf Quarter	-6.20%
Income	15.29B	P/S	3.55	EPS this Y	14.84%	Inst Trans	-1.93%	Short Ratio	1.82	Perf Half Y	-25.68%
Sales	46.69B	P/B	8.17	EPS next Y	3.61%	ROA	21.83%	Short Interest	28.24M	Perf YTD	-42.85%
Book/sh	6.02	P/C	32.29	EPS next 5Y	8.20%	ROE	68.30%	52W High	112.52 -56.31%	Perf Year	-54.94%
Cash/sh	1.52	P/FCF	16.56	EPS past 3/5Y	25.78% 21.74%	ROIC	37.50%	52W Low	45.05 9.12%	Perf 3Y	-14.39%
Dividend Est.	1.77 (3.60%)	EV/EBITDA	7.66	Sales past 3/5Y	23.46% 18.15%	Gross Margin	81.93%	Volatility	3.72% 2.70%	Perf 5Y	39.74%
Dividend TTM	1.73 (3.51%)	EV/Sales	3.78	EPS Y/Y TTM	11.24%	Oper. Margin	42.41%	ATR (14)	1.72	Perf 10Y	77.76%
Dividend Ex-Date	Aug 18, 2025	Quick Ratio	0.57	Sales Y/Y TTM	18.71%	Profit Margin	32.76%	RSI (14)	41.12	Recom	2.00
Dividend Gr. 3/5Y	28.20% 21.81%	Current Ratio	0.78	EPS Q/Q	-21.84%	SMA20	-2.92%	Beta	0.67	Target Price	63.59
Payout	35.93%	Debt/Eq	0.60	Sales Q/Q	11.80%	SMA50	-10.11%	Rel Volume	1.21	Prev Close	50.26
Employees	76302	LT Debt/Eq	0.52	Earnings	Nov 05 BMO	SMA200	-25.04%	Avg Volume	15.54M	Price	49.16
IPO	Apr 30, 1981	Option/Short	Yes / Yes	EPS/Sales Surpr.	0.21% -3.32%	Trades		Volume	18,807,646	Change	-2.19%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-27-25	Resumed	Jefferies	Underperform
Oct-01-25	Upgrade	HSBC Securities	Hold → Buy
Sep-29-25	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$47
Sep-17-25	Upgrade	Berenberg	Hold → Buy
Sep-16-25	Upgrade	Rothschild & Co Redburn	Neutral → Buy
Sep-09-25	Upgrade	Bernstein	Mkt Perform → Outperform
Aug-13-25	Upgrade	BNP Paribas Exane	Underperform → Neutral	$54
Aug-05-25	Downgrade	UBS	Buy → Neutral
Jul-31-25	Downgrade	HSBC Securities	Buy → Hold	$57
Jul-30-25	Downgrade	Barclays	Overweight → Equal Weight
Apr-17-25	Downgrade	BMO Capital Markets	Outperform → Market Perform	$64
Mar-13-25	Upgrade	Kepler	Hold → Buy
Mar-03-25	Downgrade	Stifel	Buy → Hold
Feb-12-25	Initiated	Morgan Stanley	Equal-Weight
Jan-06-25	Upgrade	Bernstein	Underperform → Mkt Perform
May-30-24	Initiated	Goldman	Buy	$156
Apr-12-24	Initiated	BMO Capital Markets	Outperform	$163
Jan-23-24	Initiated	Morgan Stanley	Overweight	$120
Jan-16-24	Resumed	UBS	Neutral
Dec-01-23	Initiated	Cantor Fitzgerald	Overweight	$120

Show Previous Ratings

Today 03:45PM	AI Frenzy: Everybody Wants NVIDIA's Magical GPUs (Zacks)
12:14PM	Pfizer CEO Albert Bourla says aggressive bid for Metsera reflects company's 'right to win' obesity market (Yahoo Finance)
12:04PM	Pfizer CEO: AI will help with medicine's next big breakthrough (Yahoo Finance Video)
11:58AM	Pfizer plans to enter GLP-1 space by 2028, CEO explains (Yahoo Finance Video)
04:25AM	1 Incredible Reason to Buy LLY's Stock in November (Motley Fool)
05:59PM	Loading…
Nov-12-25 05:59PM	This biotech is halting its work with Novo Nordisk and laying off more people (MarketWatch)
11:18AM	Novo Nordisk Cuts Wegovy Price in India as Eli Lilly's Mounjaro Leads Market (GuruFocus.com)
08:34AM	Can NVO's Ozempic, Wegovy Sales Improve in 2026 After a Subdued Q3? (Zacks)
04:35AM	Why Metsera's Share Price Is Plummeting This Week (Motley Fool)
Nov-11-25 09:55PM	Bernstein Remains Bullish on Novo Nordisk A/S (NVO) (Insider Monkey) +6.99%
03:20PM	Why cutting drug prices is pushing Eli Lilly's stock toward an all-time high (MarketWatch)
02:30PM	Why Metsera is 'in better hands' with Pfizer than Novo Nordisk (Yahoo Finance Video)
11:31AM	Eli Lilly stock soars to new highs, Novo Nordisk lags. Here's why. (Yahoo Finance Video)
11:07AM	3 Buy-And-Forget Dividend Stocks With Snowballing Payouts (24/7 Wall St.)
10:34AM	GLP-1 prices are dropping: Who exactly will benefit? (CNBC TV)
10:08AM	Loading…
10:08AM	Lilly Up 18% in a Month: Should You Buy, Sell or Hold the Stock? (Zacks)
04:25AM	Who's Winning the Intense Battle to Rule the White-Hot GLP-1 Drug Market? (Motley Fool)
01:02AM	Novo Nordisk Shares Pop After Stepping Back From Metsera Chase (GuruFocus.com)
Nov-10-25 04:59PM	Metsera Tumbles After The Pfizer-Novo Buyout Battle Ends At $10 Billion (Investor's Business Daily)
12:58PM	Eli Lilly Stock on Pace for a New High. The Zepbound Maker Just Got a Big Upgrade. (Barrons.com)
10:45AM	Novo Nordisk Walks Away from $10 Billion Fight--And the Stock Rallies Anyway (GuruFocus.com)
10:36AM	What's Next for Novo Nordisk? (The Wall Street Journal)
10:26AM	Will Lower GLP-1 Prices Undermine Novo Nordisk's Near-Term Outlook? (Zacks)
10:00AM	Pfizer Wins Battle for Weight-Loss Drugmaker Metsera. Why Novo Nordisk Is the Real Winner. (Barrons.com)
09:42AM	Pfizer Wins Obesity War Against NVO, to Buy Metsera for Around $10B (Zacks)
09:33AM	Pfizer & Metsera, Monday.com, Instacart: Trending Tickers (Yahoo Finance Video)
09:00AM	Novo Nordisk A/S (NVO) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
08:05AM	Pfizer won its fight to buy an obesity-drug maker. It took an extra $1.7 billion and a phone call. (MarketWatch)
07:47AM	Does Trump's MFN Policy Put Pharma ETFs in the Crosshairs? (Zacks)
07:32AM	Pfizer Is Buying Weight-Loss Drugmaker Metsera. Why Novo Nordisk Is the Real Winner. (Barrons.com)
06:55AM	Loading…
06:55AM	Metsera Tumbles After Novo Pulls Out of Bidding War With Pfizer (Bloomberg)
Nov-09-25 04:35AM	Hims & Hers Revenue Continues to Surge. Is It Time to Buy the Stock? (Motley Fool)
Nov-07-25 02:31PM	Analyst Report: Novo Nordisk A/S (Morningstar Research)
02:10PM	Why Novo Nordisk Stock Is Sinking This Week (Motley Fool)
01:21PM	Squawk Pod: Elon Musk's trillion dollar pay plan & obesity drug pricing - 11/07/25 Audio Only (CNBC TV)
11:28AM	Pfizer Discusses Drug Pricing Deal, Metsera Buyout Dispute on Q3 Call (Zacks)
11:22AM	The Weight-Loss Drugs Craze Is Going Strong. But Stock Investors Should Know A Few Things. (Investor's Business Daily)
10:44AM	LLY's GLP-1 Duo Boosts Sales Amid Rising Demand for Obesity Drugs (Zacks)
10:32AM	Prothena Q3 Earnings Miss Estimates, Pipeline Progress in Focus (Zacks)
10:25AM	Novo Nordisk Sees Modest Sales Impact in 2026 After U.S. Drug Price Cuts (GuruFocus.com)
09:20AM	Watch CNBC's full interview with CMS Administrator Dr. Mehmet Oz (CNBC TV)
08:20AM	Elon Musk pay deal, AI bubble worries and pharma wars (Yahoo Finance Video)
08:13AM	Pfizer and Novo Nordisk Face Off in $10 Billion Battle for Metsera (GuruFocus.com)
07:03AM	Novo shares fall after weight-loss drug price deal (Investing.com)
Nov-06-25 05:30PM	Trump inks Eli Lilly & Novo deals: How to play pharma stocks (Yahoo Finance Video)
04:12PM	'It's Getting Ugly,' Analyst Says As Pfizer Escalates Its Gloves-Off Fight For Metsera (Investor's Business Daily)
04:10PM	Trump Slashes Weight-Loss Drug Prices By Up To 74% In Deal With Lilly, Novo (Investor's Business Daily)
02:30PM	Novo Nordisk's CagriSema was associated with significant reduction in blood pressure and showed anti-inflammatory effects while reducing the proportion of patients at risk of developing heart disease over time in new analyses at ObesityWeek (PR Newswire)
01:31PM	Eli Lilly and Novo Nordisk cut deals with Trump to lower weight loss drug prices (Quartz)
01:18PM	Novo Nordisk Has Downgraded Its Outlook for the Fourth Time This Year. Here's What Investors Need to Know. (Motley Fool)
01:17PM	President Trump announces deals with Eli Lilly, Novo Nordisk to slash weight loss drug prices (CNBC TV)
01:13PM	Eli Lilly, Novo to cut GLP-1 cost; airline stocks fall on FAA cut (Yahoo Finance Video)
12:04PM	Trump White House confirms pricing deal with weight-loss-drug giants Eli Lilly, Novo Nordisk (MarketWatch)
10:46AM	ESPN & Penn end pact, Metsera bidding war, Boeing case dismissed (Yahoo Finance Video)
10:17AM	LIVE: President Trump expected announcement on weight loss drug pricing deal 11/5/2025 (CNBC TV)
Nov-05-25 06:13PM	Expect Pfizer bid to beat Novo for Metsera, says BMO's Evan David Seigerman (CNBC TV)
04:34PM	These Stocks Moved the Most Today: AMD, Humana, Novo Nordisk, Kratos, Arista Networks, Axon, Trex, Rivian, Super Micro, and More (Barrons.com)
04:31PM	Novo Nordisk CFO On Metsera, Hims And Lilly, And Why 'Hyper Growth' Has Stalled (Investor's Business Daily)
03:45PM	Analyst Report: Novo Nordisk A/S (Morningstar Research)
02:31PM	These Stocks Are Moving the Most Today: AMD, Humana, Novo Nordisk, Kratos, Arista Networks, Axon, Trex, Rivian, Super Micro, and More (Barrons.com)
02:29PM	Novo Nordisk Posts Mixed Q3, Trims Growth Outlook (GuruFocus.com)
02:00PM	Novo Nordisk AS (NVO) Q3 2025 Earnings Call Highlights: Strong Sales Growth Amid Market Challenges (GuruFocus.com)
11:54AM	Novo Nordisk Slides as GLP-1 Fatigue and Pricing Risks Cloud 2025 Outlook (GuruFocus.com)
11:37AM	Amgen's Q3 Earnings & Sales Beat, 2025 Outlook Raised, Stock Up (Zacks)
10:43AM	Novo Nordisk Stock Falls After Earnings. It Cut Guidance on These Fears. (Barrons.com)
10:30AM	Novo Nordisk Q3 Earnings & Revenues Miss, GLP-1 Drugs Face US Hurdles (Zacks)
10:12AM	Novo Nordisk CEO Mike Doustdar on $10B Metsera bid, expanding use of obesity drugs (CNBC TV)
10:00AM	Prediction: Novo Nordisk Will Soar by 2026 (Motley Fool)
09:34AM	Novo Nordisk cuts outlook, IBM layoffs, Pinterest stock plummets (Yahoo Finance Video)
08:37AM	Novo Nordisk Skids After Cutting Its Outlook For The Third Time This Year (Investor's Business Daily)
08:18AM	McDonalds and Novo Nordisk report earnings (Yahoo Finance Video)
07:45AM	Citigroup Says This Obesity Drugmaker's Stock Is Now a Buy (Motley Fool)
07:18AM	White House speaking with Novo Nordisk, Eli Lilly about selling some obesity drugs for $149/mo: WSJ (CNBC TV)
06:47AM	Novo Nordisk Cuts Growth Outlook as Weight-Loss Drug Pressures Rise (GuruFocus.com)
05:42AM	Novo Nordisk downgrades sales outlook again amid bidding war with Pfizer for Metsera (MarketWatch)
05:30AM	These Stocks Are Moving the Most Today: AMD, Pinterest, Super Micro, Arista Networks, Axon Enterprise, AppLovin, and More (Barrons.com)
05:00AM	Novo Nordisk Stock Up After Earnings. Guidance Cut on These Weight-Loss Drug Fears. (Barrons.com)
Nov-04-25 07:00PM	Qualcomm & McDonald's earnings, ADP job data: What to Watch (Yahoo Finance Video)
05:29PM	Obesity drugs may get Medicare access under deal with White House: reports (MarketWatch)
04:17PM	Hims Says It's Negotiating A New Deal With Novo Nordisk, But Shares Slide (Investor's Business Daily)
04:12PM	Novo Sweetens Its Bid For Metsera As Takeover Drama With Pfizer Escalates (Investor's Business Daily)
01:09PM	Pfizer and Novo Nordisk both raise bids for Metsera (CNBC TV)
11:15AM	Pfizer Q3 Earnings Beat Estimates, Sales Decline as COVID Demand Cools (Zacks)
10:59AM	Pfizer & Novo boost Metsera bids, Hertz stock skyrockets (Yahoo Finance Video)
10:51AM	Hims & Hers Eyes Major Weight-Loss Breakthrough With Potential Novo Nordisk Wegovy Deal (GuruFocus.com)
08:06AM	Pfizer files second lawsuit against Metsera, Novo Nordisk (TipRanks)
07:20AM	Pfizer raises and narrows full-year earnings guidance (Investing.com)
Nov-03-25 04:26PM	Metsera Calls Pfizer's Claims 'Nonsense' In Latest Buyout Battle Salvo (Investor's Business Daily)
01:23PM	Did Novo Nordisk Just Say "Checkmate" to Pfizer? (Motley Fool)
11:41AM	Novo Nordisk Before Q3 Earnings: How Should Investors Play the Stock? (Zacks)
11:13AM	Viking Therapeutics Could Be Pharmas Next Big Buyout Target (24/7 Wall St.)
09:34AM	Kimberly-Clark to buy Tylenol maker Kenvue, Iren & Microsoft deal (Yahoo Finance Video)
07:58AM	2 Beaten-Down Stocks That Could Be About to Rally (Motley Fool)
Oct-31-25 07:00PM	SNAP benefits expire, open enrollment, earnings: What to Watch (Yahoo Finance Video)
05:26PM	Pfizer Sues Novo Nordisk And Metsera To Block The Proposed $6.5 Billion Deal (Investor's Business Daily)
11:07AM	Pfizer Q3 Earnings Loom: Buy, Sell or Hold PFE Stock Ahead of Results? (Zacks)
Oct-30-25 06:53PM	Mizuho's Holtz talks what is behind Novo's bid for Metsera (CNBC TV)
04:09PM	Novo Nordisk Kicks Off Bloody Battle With Pfizer, Bidding $6.5 Billion On Metsera (Investor's Business Daily)
02:27PM	Analyst Report: Novo Nordisk A/S (Morningstar Research)
02:16PM	Pfizer said to mull suing Novo Nordisk over Metsera bid (Investing.com)

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsvaerd, Denmark.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Novo Nordisk A/S	10% Owner	May 30 '25	Proposed Sale	2.14	921,897	1,972,859		May 30 08:31 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NVO

Novo Nordisk ADR

Upgrade your FINVIZ experience